generalised anxiety disorder | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

42,796 results for “generalised anxiety disorder”

Trials

View all 38492 →

Kava for the Treatment of Generalised Anxiety Disorder: A Double-Blind Randomised Placebo-Controlled Trial

178 participants · First posted Aug 19, 2014

Active, not recruiting

Physical Exercise Augmented CBT for GAD

53 participants · First posted Feb 24, 2016

A Neuro-Technological Intervention for Adolescents With GAD

30 participants · First posted Jan 23, 2019

Drugs

View all 323 →

orexin 1 antagonist (anxiety)

ALTO-102 + ALTO-103 + ALTO-104

GPR22 modulators (cardiovascular diseases/anxiety)

Organizations

View all 19 →

MOOD AND ANXIETY RESEARCH, INC.

United States

THE PARKINSON'S AND MOVEMENT DISORDER INSTITUTE

United States

VistaGen Therapeutics

United States

News

View all 3962 →

Zydus Lifesciences Secures First Drug Approval in China for Venlafaxine ER Capsules

Definium Advances DT120 Toward Regulatory Submission After Positive Phase III Results

Entropy Neurodynamics Secures Ethics Approval for World-First 72-Patient Basket Trial of IV Psilocin Across Eight Neuropsychiatric Indications

Page 1 of 4280